Salarius Pharmaceuticals, Inc. , a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments.
Salarius Pharmaceuticals stock last closed at $0.69, up 1.92% from the previous day, and has decreased 83.15% in one year. It has underperformed other stocks in the Biotechnology industry by 0.06 percentage points. Salarius Pharmaceuticals stock is currently +52.65% from its 52-week low of $0.45, and -90.42% from its 52-week high of $7.20.
As of Apr 21, 2025, there are 1.75M shares of SLRX outstanding. The market value of SLRX is $1.20M. In the past 24 hours, 68,006 SLRX shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy SLRX stock.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, it's time to fill out some personal information so you are able to invest in SLRX stock today.
Now that you've created your account on our top ranked stock market app, you need to deposit funds:
Check out the walkthrough below for more details transferring funds into your new investment account.
After you have figured out the best place to buy Salarius Pharmaceuticals stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the upside.
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on SLRX's stock page.
You can use many financial metrics, analyses, models, and charts to gauge SLRX's intrinsic value.
Using relative valuations methods:
You can do more valuation analysis on SLRX's stock here.
You can dive deeper into what analysts are projecting on the Salarius Pharmaceuticals stock forecast page.
Last year, SLRX revenue was $0.00. Over the past five year, SLRX's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 44.31%.
You can research SLRX's earnings and revenue performance here.
Over the last year, executives and large shareholders at SLRX have not bought or sold any shares.
Dig into more about who owns SLRX shares here.
No, Salarius Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two primary options:
Press the Open Trade button and your broker will execute your order.
If you need additional assistance buying stocks on eToro, click the helpful video below:
Now that you own some shares in SLRX, you'll want to keep up with your new investment.
Create a watchlist to keep tabs on your SLRX stock.
To reiterate, here are the 6 steps to buy Salarius Pharmaceuticals stock:
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Salarius Pharmaceuticals, create your watchlist below.